Loading company…
ID 402066447 · FY 2018–2024 · 7 years
კომპანიის ძირითადი საქმიანობა არის საცალო ვაჭრობა ფარმაცევტული საქონლით.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,004 | 6,309 | 7,013 | 7,395 | 5,096 | 4,955 | 4,660 | +2.6% |
| Total COGS | -1,739 | -2,764 | -2,741 | -4,138 | -3,186 | -1,993 | -1,737 | -0.0% |
| Gross Profit | 2,265 | 3,545 | 4,272 | 3,257 | 1,910 | 2,961 | 2,923 | +4.3% |
| Gross Margin | 56.6% | 56.2% | 60.9% | 44.0% | 37.5% | 59.8% | 62.7% | |
| Total Operating Expenses | -856 | -1,404 | -2,728 | -3,058 | -1,183 | -2,571 | -3,223 | +24.7% |
| EBITDA | 1,409 | 2,141 | 1,544 | 199 | 727 | 391 | -300 | nmf |
| EBITDA Margin | 35.2% | 33.9% | 22.0% | 2.7% | 14.3% | 7.9% | -6.4% | |
| Total D&A | -8 | -25 | -33 | -131 | -41 | -66 | -47 | +35.8% |
| EBIT / Operating Income | 1,401 | 2,116 | 1,511 | 68 | 686 | 325 | -347 | nmf |
| Total Interest Expense | 0 | 0 | -104 | -46 | -35 | -27 | -32 | -25.9% |
| Total Other Income | 0 | 1 | 232 | -190 | 189 | 342 | 406 | nmf |
| Profit Before Tax | 1,401 | 2,117 | 1,638 | -168 | 841 | 639 | 28 | -48.1% |
| Total Income Tax | 0 | 0 | 0 | -310 | -21 | -29 | 0 | -69.2% |
| Net Profit / (Loss) | 1,401 | 2,117 | 1,603 | -330 | 873 | 701 | 28 | -48.1% |
| Net Margin | 35.0% | 33.6% | 22.9% | -4.5% | 17.1% | 14.2% | 0.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
Ownership & directors from companyinfo.ge (public corporate registry).